Market Overview

UPDATE: Goldman Sachs Downgrades Emulex to Sell on Deteriorating Risk./Reward

Related ELX
Barclays Is Overweight Avago, Sees 'Room For M&A'
Apple's Quarter A Positive Read For Avago Technologies, Citi Says

Goldman Sachs reduced its rating on Emulex (NYSE: ELX) from Neutral to Sell and cut its price target from $7 to $6.

Goldman Sachs commented, "The absence of a positive catalyst—the Romley-driven product cycle—has made us incrementally negative on ELX shares. We believe that as adoption of this new platform remains tepid in the quarters ahead, investors will increasingly re-focus on the long-term secular challenges facing Emulex. Moreover, the absence of a product cycle boost introduces more near-term cyclical risk for the server market in general. We expect this to become apparent with the earnings reports of Emulex and its key customers, supply chain partners, and competitors."

Emulex closed at $7.35 on Friday.

Latest Ratings for ELX

Oct 2014DA DavidsonUpgradesUnderperformNeutral
Aug 2014BarclaysDowngradesEqual-WeightUnderweight
May 2014Summit Research PartnersDowngradesBuyHold

View More Analyst Ratings for ELX
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Downgrades Intraday Update Analyst Ratings


Related Articles (ELX)

View Comments and Join the Discussion!

Partner Center